Skip to main content

Advertisement

SpringerLink
Log in

The Mid-Term Effects of Transit Bipartition with Sleeve Gastrectomy on Glycemic Control, Weight Loss, and Nutritional Status in Patients with Type 2 Diabetes Mellitus: a Retrospective Analysis of a 3-Year Follow-up

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Metabolic surgery is an effective treatment method for glycemic control and weight loss in obese patients with type 2 diabetes mellitus (T2DM). This study aimed to present the mid-term metabolic effects and weight loss results of the patients with T2DM who underwent transit bipartition with sleeve gastrectomy (TB-SG).

Methods

A total of 32 obese patients with T2DM who underwent TB-SG were included in the study. The T2DM remission status after surgery was evaluated. The postoperative glycemic variables, weight loss, lipid profile, and nutritional profile were also compared with the baseline values.

Results

At 36 months after surgery, T2DM remission occurred in 27 patients (84.3%) and the mean BMI decreased from 44.70 ± 9.34 to 29.75 ± 2.19 kg/m2. The percentage of total weight loss (TWL) and excess weight loss (EWL) was 33.84% and 77.19%, respectively. The mean LDL values significantly decreased compared to baseline; however, the mean HDL did not significantly differ. No significant difference was observed regarding the mean albumin, vitamin B12, and folic acid levels.

Conclusion

TB-SG procedure seems promising in terms of T2DM remission and weight loss with less malnutrition and vitamin deficiency in treating obese patients with T2DM.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rahier J, Guiot Y, Goebbels R, et al. Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10:32–42.

    Article  PubMed  Google Scholar 

  2. Hossain P. Obesity and diabetes in the developing world-a growing challenge (vol 356, pg 213, 2007). N Engl J Med. 2007;356(9):973.

    Article  Google Scholar 

  3. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Yormaz S, Yılmaz H, Ece I, et al. Laparoscopic ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients. Obes Surg. 2018;28(1):77–86.

    Article  PubMed  Google Scholar 

  5. Brown E, Wilding JP, Barber TM, et al. Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: mechanistic possibilities. Obes Rev. 2019;20(6):816–28.

    Article  PubMed  CAS  Google Scholar 

  6. Kapeluto JE, Tchernof A, Masckauchan D, et al. Ten-year remission rates in insulin-treated type 2 diabetes after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2020;16:1701–12.

    Article  PubMed  Google Scholar 

  7. Bianchi A, Pagan-Pomar A, Jimenez-Segovia M, et al. Biliopancreatic diversion in the surgical treatment of morbid obesity: long-term results and ,etabolic consequences. Obes Surg. 2020:1–9.

  8. Turcotte A-F, Grenier-Larouche T, Lacombe J, et al. Association between changes in bioactive osteocalcin and glucose homeostasis after biliopancreatic diversion. Endocrine. 2020:1–10.

  9. Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.

    Article  PubMed  Google Scholar 

  10. Cohen RV, Shikora S, Petry T, et al. The diabetes surgery summit II guidelines: a disease-based clinical recommendation. Obes Surg. 2016;26(8):1989–91.

    Article  PubMed  Google Scholar 

  11. Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12(6):1144–62.

    Article  PubMed  Google Scholar 

  12. Ghio B, Jiménez A, Corcelles R, et al. Midterm effects of bariatric surgery in patients with insulin-treated type 2 diabetes. Surg Obes Relat Dis. 2017;13(12):2004–9.

    Article  PubMed  Google Scholar 

  13. Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256(1):104–10.

    Article  PubMed  Google Scholar 

  14. Karaca FC. Effects of sleeve gastrectomy with transit bipartition on glycemic variables, lipid profile, liver enzymes, and nutritional status in type 2 diabetes mellitus patients. Obes Surg. 2020:1–9.

  15. Brethauer SA, Kim J, El Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25(4):587–606.

    Article  PubMed  Google Scholar 

  16. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5.

    Article  PubMed  Google Scholar 

  17. Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018. Obes Surg. 2019;29(3):782–95.

    Article  PubMed  Google Scholar 

  18. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    Article  PubMed  CAS  Google Scholar 

  19. Misra S, Nandhini BD, Christinajoice S, et al. Is laparoscopic Roux-en-Y gastric bypass still the gold standard procedure for Indians? Mid- to long-term outcomes from a tertiary care center. Obes Surg. 2020;30(11):4482–93.

    Article  PubMed  Google Scholar 

  20. Lebel S, Dion G, Marceau S, et al. Clinical outcomes of duodenal switch with a 200-cm common channel: a matched, controlled trial. Surg Obes Relat Dis. 2016;12(5):1014–20.

    Article  PubMed  Google Scholar 

  21. Mason EE, Ito C. Gastric bypass. Ann Surg. 1969;170(3):329–39.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Topart P, Becouarn G, Ritz P. Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients. Surg Obes Relat Dis. 2013;9(4):526–30.

    Article  PubMed  Google Scholar 

  23. Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.

    Article  PubMed  Google Scholar 

  24. Scopinaro N, Gianetta E, Civalleri D, et al. The bilio-pancreatic bypass for functional surgical treatment of obesity. Minerva Med. 1979;70(52):3537–47.

    PubMed  CAS  Google Scholar 

  25. Nelson DW, Blair KS, Martin MJ. Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Arch Surg. 2012;147(9):847–54.

    Article  PubMed  Google Scholar 

  26. von Drygalski A, Andris DA, Nuttleman PR, et al. Anemia after bariatric surgery cannot be explained by iron deficiency alone: results of a large cohort study. Surg Obes Relat Dis. 2011;7(2):151–6.

    Article  Google Scholar 

  27. Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26(11-12):1031–7.

    Article  PubMed  CAS  Google Scholar 

  28. Blume CA, Boni CC, Casagrande DS, et al. Nutritional profile of patients before and after Roux-en-Y gastric bypass: 3-year follow-up. Obes Surg. 2012;22(11):1676–85.

    Article  PubMed  Google Scholar 

  29. Sala P, Belarmino G, Torrinhas RS, et al. Gastrointestinal transcriptomic response of metabolic vitamin B12 pathways in Roux-en-Y gastric bypass. Clin Transl Gastroenterol. 2017;8(1):e212.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Lupoli R, Lembo E, Saldalamacchia G, et al. Bariatric surgery and long-term nutritional issues. World J Diabetes. 2017;8(11):464–74.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Santoro S, Malzoni CE, Velhote MC, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006;16(10):1371–9.

    Article  PubMed  Google Scholar 

  32. Santoro S. From bariatric to pure metabolic surgery: new concepts on the rise. Ann Surg. 2015;262(2):e79–80.

    Article  PubMed  Google Scholar 

  33. Reis CE, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index< 35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–72.

    Article  PubMed  CAS  Google Scholar 

  34. Liu S, Zhang G, Wang L, et al. The entire small intestine mediates the changes in glucose homeostasis after intestinal surgery in Goto-Kakizaki rats. Ann Surg. 2012;256(6):1049–58.

    Article  PubMed  Google Scholar 

  35. Vella A. Enteroendocrine secretion after roux-en-Y gastric bypass: is it important? Neurogastroenterol Motil. 2013;25(1):1–3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Mingrone G, Nolfe G, Gissey GC, et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia. 2009;52(5):873–81.

    Article  PubMed  CAS  Google Scholar 

  37. Azevedo FR, Santoro S, Correa-Giannella ML, et al. A prospective randomized controlled trial of the metabolic effects of sleeve gastrectomy with transit bipartition. Obes Surg. 2018;28(10):3012–9.

    Article  PubMed  Google Scholar 

  38. Asmar M, Holst JJ. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes. 2010;17(1):57–62.

    Article  PubMed  CAS  Google Scholar 

  39. Bilecik T. Metabolic effects of sleeve gastrectomy with transit bipartition in obese females with type 2 diabetes mellitus: results after 1-year follow-up. Obes Surg. 2019;29(3):805–10.

    Article  PubMed  Google Scholar 

  40. Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

    Article  PubMed  Google Scholar 

  41. Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.

    Article  PubMed  Google Scholar 

  42. Leonetti F, Capoccia D, Coccia F, et al. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment. Arch Surg. 2012;147(8):694–700.

    Article  PubMed  CAS  Google Scholar 

  43. Hirth M, Weiss C, Hardt P, et al. Analysis of the course of chronic pancreatitis: pancreatic burnout rates are only increased in a subgroup of patients with alcoholic chronic pancreatitis. Pancreas. 2019;48(5):726–33.

    Article  PubMed  Google Scholar 

  44. Iwase H, Kobayashi M, Nakajima M, et al. The ratio of insulin to C-peptide can be used to make a forensic diagnosis of exogenous insulin overdosage. Forensic Sci Int. 2001;115(1-2):123–7.

    Article  PubMed  CAS  Google Scholar 

  45. Abdemur A, Han S-M, Menzo EL, et al. Reasons and outcomes of conversion of laparoscopic sleeve gastrectomy to Roux-en-Y gastric bypass for nonresponders. Surg Obes Relat Dis. 2016;12(1):113–8.

    Article  PubMed  Google Scholar 

  46. Iannelli A, Debs T, Martini F, et al. Laparoscopic conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: indications and preliminary results. Surg Obes Relat Dis. 2016;12(8):1533–8.

    Article  PubMed  Google Scholar 

  47. Boru CE, Greco F, Giustacchini P, et al. Short-term outcomes of sleeve gastrectomy conversion to RY gastric bypass: multi-center retrospective study. Langenbeck's Arch Surg. 2018;403(4):473–9.

    Article  Google Scholar 

  48. Braghetto I, Korn O, Burgos A, et al. When should be converted laparoscopic sleeve gastrectomy to laparoscopic Roux-en-Y Gastric bypass due to gastroesophageal reflux? ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2020;33(4)

  49. Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract. 2005;20(5):517–25.

    Article  PubMed  Google Scholar 

  50. Hedberg J, Hedenström H, Karlsson FA, et al. Gastric emptying and postprandial PYY response after biliopancreatic diversion with duodenal switch. Obes Surg. 2011;21(5):609–15.

    Article  PubMed  Google Scholar 

  51. Kim TY, Kim S, Schafer AL. Medical Management of the Postoperative Bariatric Surgery Patient. [Updated 2020 Aug 24]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK481901/

  52. Coupaye M, Calabrese D, Sami O, et al. Effectiveness of ursodeoxycholic acid in the prevention of cholelithiasis after sleeve gastrectomy. Obes Surg. 2019;29(8):2464–9.

    Article  PubMed  Google Scholar 

  53. Huang C-K, Liu C-C, Hsin M-C, et al. Sleeve and sleeve plus. Ann Laparosc Endosc Surg. 2017;2(1):24.

    Article  Google Scholar 

  54. Huang C-K, Katakwar A. Sleeve plus procedures: need of time. Surg Today. 2019:1–4.

  55. Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.

    Article  PubMed  CAS  Google Scholar 

  56. Huang C-K, Goel R, Tai C-M, et al. Novel metabolic surgery for type II diabetes mellitus: loop duodenojejunal bypass with sleeve gastrectomy. Surg Laparosc Endosc PercutanTechn. 2013;23(6):481–5.

    Google Scholar 

  57. Kumar KH, Ugale S, Gupta N, et al. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009;11(12):785–9.

    Article  PubMed  Google Scholar 

  58. Langer F, Hoda MR, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15(7):1024–9.

    Article  PubMed  CAS  Google Scholar 

  59. Vidal J, Ibarzabal A, Nicolau J, et al. Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg. 2007;17(8):1069–74.

    Article  PubMed  CAS  Google Scholar 

  60. Saarinen T, Räsänen J, Salo J, et al. Bile reflux scintigraphy after mini-gastric bypass. Obes Surg. 2017;27(8):2083–9.

    Article  PubMed  Google Scholar 

  61. Gagner M. Laparoscopic sleeve gastrectomy with ileal interposition (SGIT): a modified duodenal switch for resolution of type 2 diabetes mellitus in lesser obese patients (BMI< 35). World J Surg. 2011;35(1):109–10.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Faculty of Medicine, Selcuk University, 42075, Konya, Turkey

    Akin Calisir, Ilhan Ece, Huseyin Yilmaz, Husnu Alptekin, Fahrettin Acar, Serdar Yormaz, Bayram Colak & Mustafa Sahin

Authors
  1. Akin Calisir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilhan Ece
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huseyin Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Husnu Alptekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fahrettin Acar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Serdar Yormaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bayram Colak
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mustafa Sahin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akin Calisir.

Ethics declarations

Ethics Approval and Consent to Participate

The need for patient informed consent for this retrospective study was waived by the institutional review board.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• TB-SG leads significant weight loss and diabetes remission in obese T2DM patients

• TB-SG can be considered a safe and effective metabolic surgical method

• TB-SG may be a remarkable alternative to other metabolic surgeries

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calisir, A., Ece, I., Yilmaz, H. et al. The Mid-Term Effects of Transit Bipartition with Sleeve Gastrectomy on Glycemic Control, Weight Loss, and Nutritional Status in Patients with Type 2 Diabetes Mellitus: a Retrospective Analysis of a 3-Year Follow-up. OBES SURG 31, 4724–4733 (2021). https://doi.org/10.1007/s11695-021-05536-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-021-05536-1

Keywords

Search

Navigation